Jacobs LD, Beck RW, Simon JH, et al. The CHAMPS Study Group. Intramuscular Interferon Beta-1-a Therapy Initiated During A First Demyelinating Event in Multiple Sclerosis. NEJM 2000;343(13):898-904.

CHAMPS Study Group (J Simon, Publications Committee Member) Interferon b-1a for Optic Neuritis Patients at High Risk for Multiple Sclerosis. Am J Ophth 2001;132(4):463-471.

CHAMPS Study Group (J Simon, Corresponding Author). Baseline MRI Characterization of Patients at High Risk for MS. Results from the CHAMPS trial. Multiple Sclerosis, 2002, in press.

CHAMPS Study Group ( J Simon, Publications Committee Member). Interferon b-1a for an Initial Demyelinating Event: Results of the CHAMPS Trial in Subgroups. Ann Neurology, 2002, in press.

CHAMPS Study Group ( J Simon, Corresponding Author) MR Predictors of Early MS . Submitted 2002.

Simon, JH, Jacobs LD, Campion M et al. MSCRG Group . Magnetic Resonance Studies of Intramuscular r-Interferon Beta-1a for Relapsing Multiple Sclerosis. Annals of Neurology, 1998;43:79-87.

Simon JH, Jacobs LD, Campion MK et al. MSCRG Group. A Longitudinal Study of Brain Atrophy in Relapsing Multiple Sclerosis. Neurology, 1999;53(1):139-148.

Kinkel RP, Simon JH, Baron B. Bimonthly Cranial MRI Activity Following an Isolated Monosymptomatic Demyelinating Syndrome: Potential Outcome Measures for Future Multiple Sclerosis "Prevention Trials". Multiple Sclerosis, 1999;5:307-312.

Rudick RA, Fisher E, Lee JC, Simon J, Jacobs L, MSCRG. Use of the brain parenchymal
fraction to measure whole brain atrophy in relapsing-remitting MS. Neurology, 1999;53:1698-1704

Simon JH, Lull J, Jacobs LD, et al. The Multiple Sclerosis Collaborative Research Group (MSCRG). A Longitudinal Study of Tl-hypointense Lesions in Relapsing MS: MSCRG Trial of Interferon b-1a. Neurology, 2000;55(2):185-192.